Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.
52 Stocks Moving In Monday’s Mid-Day Session
Gainers
DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Praxis Precision Posts Disappointing Data From Depression Study
Praxis Precision Medicines Inc’s (NASDAQ:PRAX) Phase 2/3 Aria Study of PRAX-114 for major depressive disorder (MDD) did not achieve statistical…
Praxis Precision Medicines Reports Topline Results From PRAX-944 Phase 2a Study In Essential Tremor Patients; Co. Reports ‘PRAX-944 demonstrated clinically meaningful functional improvement in essential tremor patients in Part B of Phase 2a study’
Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.